Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study

Detalles Bibliográficos
Autores principales: Benatar, Michael, Wuu, Joanne, Andersen, Peter M., Bucelli, Robert C., Andrews, Jinsy A., Otto, Markus, Farahany, Nita A., Harrington, Elizabeth A., Chen, Weiping, Mitchell, Adele A., Ferguson, Toby, Chew, Sheena, Gedney, Liz, Oakley, Sue, Heo, Jeong, Chary, Sowmya, Fanning, Laura, Graham, Danielle, Sun, Peng, Liu, Yingying, Wong, Janice, Fradette, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606151/
https://www.ncbi.nlm.nih.gov/pubmed/36175782
http://dx.doi.org/10.1007/s13311-022-01286-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606151/
https://www.ncbi.nlm.nih.gov/pubmed/36175782
http://dx.doi.org/10.1007/s13311-022-01286-9

Ejemplares similares